Compare Enveric Biosciences Inc (ENVB) vs Public Storage (PSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Public Storage — how do they compare? Enveric Biosciences Inc trades at $1.44 (market cap $6.80M), while Public Storage trades at $288.19 (market cap $53.35B). The key difference: Public Storage is far larger — about 7845.6× Enveric Biosciences Inc's market cap, and Public Storage pays a 4.2% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Public Storage for 130 Days on average.
| ENVB | PSA | |
|---|---|---|
Market Cap | $6.80M | $53.35B |
Volume | 64,867 | 1,176,034 |
Sector | Health | Real Estate |
52-Week High | $10.80 | $330.47 |
52-Week Low | $1.27 | $258.44 |
Typical Hold Time | 14 Days | 130 Days |
Enterprise Value | -$1.49M | $67.62B |
Dividend Yield | — | 4.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.45, down 3.01% on the day, with a bearish technical signal driven by moving averages. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten quarterly EPS expectations. Recent positive developments include a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in investor conferences.
The outlook is mixed; analyst consensus is 75% buy with strong earnings beats, but high negative ROE/ROA and operational cash burn pose significant risks. Investment opportunity hinges on successful drug development, while key risks include funding needs and clinical trial outcomes.
Public Storage (PSA) trades at $286.07, up 1.45% with recent earnings beats and strong profitability metrics including 41.8% net income margin. Technical indicators show bearish momentum with support at $277, while fundamentals reveal stable revenue growth and a $3.00 dividend. The company recently completed its Public Storage Canada acquisition and issued C$400 million in senior notes.
The stock presents a mixed outlook with analyst consensus target of $328.33 offering 15% upside, though technical weakness and valuation premiums pose risks. Key opportunities include operational momentum and reliable yield, while headwinds include oversupply concerns and interest rate sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →
